Healthtech Startups

iFocus Health provides a data-driven digital health platform that helps patients and caregivers make informed treatment decisions for ADHD, combining AI, bioinformatics, and clinical expertise to improve treatment outcomes.

1 investor

IFP Labs operates an integrated network of accredited analytical laboratories in Germany and the UK providing food safety testing, contaminant analysis, and regulatory compliance services. Services span chemical, physical, and microbiological testing for food, feed, water, environmental, and pharmaceutical samples, including nutritional profiling, allergen testing, and label compliance.

1 investor

Galenico is a CDMO (contract development and manufacturing organization) that develops and produces liquid, semi-solid, and solid pharmaceutical forms, covering formulation development, stability studies, manufacturing, filling, and packaging. It serves the medical device, cosmetics, and food supplement sectors, operating under Good Manufacturing Practices with production based in Portugal.

1 investor

Igea Medical develops and manufactures medical devices that use reversible electroporation to treat tumors (electrochemotherapy) and vascular malformations (electrosclerotherapy). The company sells and rents its devices to healthcare providers, based in Italy.

1 investor

IGNIA is a venture capital fund founded in 2007 that invests in early-stage startups solving problems in emerging markets, with a focus on Latin America market expansion. The fund serves as a bridge for regional startups pursuing international growth and for global startups entering Latin America.

1 investor

IGS develops imaging and visualization technology based on inverse scattering theory to enable observation of previously invisible structures and phenomena. The company applies this core technology to solve problems in medical imaging, energy, infrastructure, and security sectors.

1 investor

Clinical Medical Services provides durable medical equipment, home health care, respiratory equipment, inhalation medications, home infusion services, and orthotics and prosthetics to patients across Puerto Rico through an integrated healthcare delivery system.

1 investor

iheed offers accredited postgraduate online medical courses and qualifications developed with universities and training bodies such as the University of Warwick and the Royal College of Physicians of Ireland. It serves healthcare professionals and clinicians globally with programs in areas like healthcare leadership, medical education, mental health, clinical research, and public health.

1 investor

IHH Healthcare is one of the world's largest private healthcare services providers, operating an integrated network of 89 hospitals across 10 countries. The company delivers hospital, primary care, and ancillary healthcare services under trusted brands including Acibadem, Mount Elizabeth, Gleneagles, and Fortis.

1 investor

1 investor

iipuda is a platform that matches users with human-verified dermatology, aesthetic, and dental clinics and authentic K-beauty products in Korea, offering free personalized clinic recommendations at local Korean prices. It acts as an intermediary connecting patients with vetted medical partners rather than providing treatments directly.

1 investor

Iiwari is a Finnish technology company that develops indoor positioning and location-based tracking systems, built on research from the VTT research institute and multiple patents. Its solutions serve businesses in sectors such as healthcare and manufacturing, including nurse-alert and safety systems for nursing homes and hospitals as well as tool and process tracking in industrial settings.

1 investor

Kidsmile (青苗儿童口腔) operates a chain of pediatric dental clinics across China, providing orthodontic and facial development management services for children. The company uses digital data and proprietary bite-guidance induction technology to prevent and treat malocclusion early.

1 investor

IKKO is developing a new medical imaging modality designed to be wearable, accurate, safe, and low-cost. The company operates in the medical imaging and health technology space.

1 investor

IKOMED Technologies develops medical devices to improve patient outcomes and clinical workflows for medical staff. The company combines deep expertise in medical device design, manufacturing, and commercialization with clinical leadership from cardiovascular surgery and interventional radiology.

1 investor

ILiAD Biotechnologies is a clinical-stage biotechnology company developing vaccines and treatments for disease caused by Bordetella pertussis, with a lead candidate, BPZE1, a next-generation pertussis vaccine that has completed four Phase 2 clinical trials. It operates a wholly-owned subsidiary, BioLyo Technologies, a contract development and manufacturing organization for live bacterial products based in Ghent, Belgium.

1 investor

Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.

1 investor

ILIMEX develops UV-C air sterilisation systems engineered for poultry, agricultural, and agri-food environments to eliminate airborne pathogens and strengthen biosecurity. The company's patented technology reduces airborne microbial load beyond conventional filtration and includes real-time air quality monitoring for disease management.

1 investor

Illumacell is a medtech company developing photodynamic therapy (PDT) treatments for cancer, including solid tumors, with preclinical research showing tumor reduction in animal models. It works on integrating light-based cancer therapies with traditional oncology treatments.

1 investor

Illumen Therapeutics is a biotech company developing first-in-class PARN inhibitor drugs that increase functional p53, a tumor suppressor, as a treatment for aggressive cancers. Its drug development focuses on targeting p53 dysregulation to improve cancer patient survival.

1 investor

Illuminare Bio develops Illuminare-1, a fluorescent imaging agent that makes peripheral nerves visible during surgery to help surgeons avoid nerve injury. The product is administered intravenously pre-operatively and works with standard surgical equipment across multiple procedure types including prostatectomy, mastectomy, hernia repair, and spinal surgery.

1 investor

illumiSonics develops MLI™, a proprietary molecular imaging platform that extracts diagnostic information from unstained tissue samples for use in pathology, surgical imaging, and ophthalmology. The technology enables virtual histology and AI-powered diagnostics without destructive sample consumption, targeting pharmaceutical companies, clinical labs, and surgical centers.

1 investor

ILM Health (Interactive Lifestyle Management) is building a digital health network aimed at improving healthcare access for Medicaid and other underserved populations. The company focuses on health equity for these communities in the United States.

1 investor

ilumivu builds software platforms for behavioral and clinical research, including tools for running clinical trials, patient engagement, and multisite collaborative research using wearable and mobile technology. The company originated in support of families of children with autism and works with researchers, clinicians, and healthcare organizations.

1 investor